Dr. Lentnek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
17087 Ryton Lane
Boca Raton, FL 33496Phone+1 404-798-7152
Education & Training
- University of Pennsylvania Health SystemFellowship, Infectious Disease, 1973 - 1975
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1973 - 1975
- George Washington UniversityResidency, Internal Medicine, 1972 - 1973
- University of ConnecticutResidency, Internal Medicine, 1969 - 1970
- Hartford HospitalInternship, Transitional Year, 1968 - 1969
- Tufts University School of MedicineClass of 1968
Certifications & Licensure
- NY State Medical License 1971 - 2026
- NJ State Medical License 1990 - 2025
- GA State Medical License 1993 - 2021
- CT State Medical License 1971 - 2016
- PA State Medical License 1973 - 1994
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- National Board of Physicians and Surgeons Infectious Disease
- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Teacher of the Year AOA, 2009
Clinical Trials
- Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis Start of enrollment: 2004 Jan 01
Publications & Presentations
PubMed
- 1089 citationsFidaxomicin versus Vancomycin for Clostridium difficile InfectionThomas J. Louie, Mark A. Miller, Kathleen M. Mullane, Karl Weiss, Arnold Lentnek
The New England Journal of Medicine. 2011-02-02 - 189 citationsTelavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive PathogensEthan Rubinstein, Tahaniyat Lalani, G. Ralph Corey, Zeina A. Kanafani, Esteban C. Nannini
Clinical Infectious Diseases. 2011-01-01 - 225 citationsTelavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin-Structure Infections Caused by Gram-Positive OrganismsMartin E. Stryjewski, Donald R. Graham, Samuel E. Wilson, William O'Riordan, David M. Young
Clinical Infectious Diseases. 2008-06-01
Industry Relationships
- Consultant, Gerson Lehrman Group2010 - Present
- Consultant, Guidepoint Global2010 - Present
- Consultant, Senzar Capital Management2008 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: